ReproCell Stock

ReproCell ROA

The Return on Assets (ROA) of ReproCell (4978.T) as of Sep 4, 2026 is 1.07 %. In the previous year, Return on Assets (ROA) was -0.35 % — a change of -407.64% (higher).

ROA

1.07 %

YoY

-407.64%

Last updated:

In 2026, ReproCell's return on assets (ROA) was 1.07 %, a -407.64% increase from the -0.35 % ROA in the previous year.

The ReproCell ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2018
-32.92 JPY
Jan 1, 2019
-8.03 JPY
Jan 1, 2020
-15.51 JPY
Jan 1, 2021
-13.44 JPY
Jan 1, 2022
-7.10 JPY
Jan 1, 2023
-3.65 JPY
Jan 1, 2024
-0.35 JPY
Jan 1, 2025
1.07 JPY
The ReproCell ROA history
YEARROAYoY
1.07 %-407.64%
-0.35 %-90.50%
-3.65 %-48.57%
-7.10 %-47.13%
-13.44 %-13.38%
-15.51 %+93.19%
-8.03 %-75.61%
-32.92 %+183.62%
-11.61 %-52.84%
-24.61 %+313.75%
-5.95 %+140.75%
-2.47 %
Access this data via the Eulerpool API

ReproCell Stock analysis

What does ReproCell do? ReproCell, Inc. is a company that was founded in 2003 and specializes in the research and manufacture of cell cultures. The company is based in Yokohama, Japan and operates worldwide. Its business model includes providing services and products to support research and development activities in the field of regenerative medicine and cell therapy. The company is divided into three main divisions: the Biorepository Division, which provides human cells and tissues for research purposes; the Cell Manufacturing Division, which develops production processes for cell therapy products; and the Drug Discovery Division, which supports drug development through screening and in vitro testing. ReproCell offers a variety of cell cultures, including stem cells from various sources, as well as related media, reagents, and tools for cultivation and application. In addition, the company offers services in cell therapy production, working closely with customers to provide customized and high-quality therapies. ReproCell also supports drug and compound research through screening and in vitro testing, with various platforms available for the identification and evaluation of new compounds. The company has a history of growth and has become a leading player in the field of cell culture and cell therapy production. In conclusion, ReproCell plays a significant role in regenerative medicine and cell therapy production, offering a wide range of products and services to support research and development in these areas. It is poised to continue its growth and contribute to the development of new therapies in the future. ReproCell is one of the most popular companies on Eulerpool.

ROA Details

Understanding ReproCell's Return on Assets (ROA)

ReproCell's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing ReproCell's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider ReproCell's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in ReproCell’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about ReproCell stock

Return on Assets (ROA) of ReproCell is 1.07 % in 2026.

Return on Assets (ROA) of ReproCell changed from -0.35 % to 1.07 %, representing a -407.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) ReproCell since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s ReproCell with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

Profitability — ReproCell

All Key Metrics — ReproCell